Table 5.
Risk factor | Number who developed sepsis (n = 71) | Number who did not develop sepsis (n = 71) | P value | Likelihood ratio | Significance |
---|---|---|---|---|---|
Neutropenia | |||||
Yes | 64 (90.1%) | 9 (12.7%) | 9.19 × 10−15 | 6.81 × 10−23 | Significant |
No | 7 (9.90%) | 62 (87.3%) | |||
Present chemotherapy | |||||
Yes | 26 (36.6%) | 13 (18.3%) | 0.023 | 0.014 | Significant |
No | 45 (63.4%) | 58 (81.7%) | |||
Mucosal barrier injury | |||||
Yes | 25 (35.2%) | 13 (18.3%) | 0.036 | 0.022 | Significant |
No | 46 (64.8%) | 58 (81.7%) | |||
Presence of central line | |||||
Yes | 24 (33.8%) | 4 (5.6%) | 3.32 × 10−05 | 1.07 × 10−05 | Significant |
No | 47 (66.2%) | 67 (94.4%) | |||
History of immunosuppressive therapy | |||||
Yes | 21 (29.6%) | 11 (15.5%) | 0.05 | 0.043 | Significant |
No | 50 (70.4%) | 60 (84.5%) | |||
H/o bone marrow puncture | |||||
Yes | 67 (94.4%) | 58 (67.6%) | 6.86 × 10−05 | 2.29 × 10−05 | Significant |
No | 4 (5.6%) | 23 (32.4%) | |||
Past H/o hospitalization | |||||
Yes | 37 (52.1%) | 41 (57.7%) | 0.613 | 0.5 | Not significant |
No | 34 (47.9%) | 30 (42.3%) | |||
Past H/o chemotherapy | |||||
Yes | 14 (19.7%) | 09 (12.7%) | 0.363 | 0.253 | Not significant |
No | 57 (80.3%) | 62 (87.3%) | |||
H/o blood transfusion | |||||
Yes | 36 (50.7%) | 35 (49.3%) | 1 | 0.867 | Not significant |
No | 35 (49.3%) | 36 (50.7%) |